Accelerated decline in apolipoprotein E-ε homozygotes with Alzheimer's disease

Neurology

Volumn 51, Issue 1, 1998, Pages 149-153

  Craft, Suzanne ^a,b   Teri, L ^a   Edland, S D ^a   Kukull, W A ^a   Schellenberg, G ^a   McCormick, W C ^a   Bowen, J D ^a   Larson, E B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DISEASE SEVERITY; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0031814593     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.149     Document Type: Article

References (34)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
2. Strittmatter WJ, Weisgraber KH, Huang, D, et al. Binding of human apolipoprotein E to synthetic amyloid βA4 peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102.
3. Kamboh MI. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum Biol 1995;67:195-215.
4. Poirier J, Hess M, May P, Finch CE. Apolipoprotein E- and GFAP-RNA in hippocampus during reactive synaptogenesis and terminal proliferation. Mol Brain Res 1991;11:97-106.
5. Poirier J, Baccichet A, Dea D, Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rat. Neuroscience 1993;55:81-90.
6. Nathan BP, Chang KC, Bellosta S, et al. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 1995;270:19791-19799.
7. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein-∈4 in patients with Alzheimer's disease. Neurology 1995;45:555-557.
8. Nicoll JAR, Roberts GW, Graham DI. Apolipoprotein E ∈4 allele is associated with deposition of amyloid β-protein following head injury. Nat Med 1995;1:135-137.
9. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995;92:4725-4727.
10. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E ∈4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
11. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
12. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995;183:32-34.
13. Soininen H, Kosunen O, Helisalmi S, et al. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ∈4 allele. Neurosci Lett 1995; 187:79-82.
14. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-1247.
15. Dal Forno G, Rasmusson DX, Brandt J, et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996;53:345-350.
16. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47: 444-448.
17. Kurz A, Egensperger R, Haupt M, et al. Apolipoprotein E ∈4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996;47:440-443.
18. Mattis S. Dementia rating scale. Tampa, FL: Psychological Assessment Resources, 1988.
19. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:39-44.
20. Larson EB, Kukull WA, Teri L, et al. University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988. Aging 1990;2:404-408.
21. Miller SA, Dykes DD, Polefsky HF. A simple salting out procedure for extracting DNA from human enucleated cells. Nucl Acids Res 1988;16:1215.
22. Emi M, Wu LL, Robertson MA, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3:373-377.
23. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
24. Morris JC, Edland S, Clark C, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457-2465.
25. Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1991:739-839.
26. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
27. Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the ∈4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995:37;596-604.
28. Stern Y, Brandt J, Albert M, et al. The absence of an apolipoprotein ∈4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997;41:615-620.
29. Tsai MS, Tangalos EG, Peterson RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994;54: 643-649.
30. Wisniewski T, Golabek A, Matsubara E, et al. Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 1993;192:359-365.
31. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171.
32. Neary D, Snowden JS, Mann DMA, et al. Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry 1986;49: 229-237
33. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42: 631-639.
34. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995;52:81-88.